A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

Remember "Baby KJ"? Now CRISPR pioneers have partnered with the Chan Zuckerberg Initiative to launch center for curing rare ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Trisomy is a genetic condition characterized by the presence of an extra chromosome. This means that the affected person has ...

Martin Kampmann, PhD, delivers the 2025 Byers Lecture. Photo by Sonya YruelWhen Martin Kampmann, PhD, set out to explore the ...

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

Crispr investors have had a year to put aside so far, with the stock down 25%. Read more on CRSP's execution risks, high valuation, and speculative pipeline raise concerns.

CRISPR, which stands for clustered regularly interspaced short palindromic repeats, is part of that bacterial immune system. "Palindromic" means any sequence that reads the same forward and backward.